Mitoxantrone Recruiting Phase 3 Trials for Relapsed/Refractory Acute Myeloid Leukemia With FLT3 Activating Mutations Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03250338Study Investigating the Efficacy of Crenolanib With Chemotherapy vs Chemotherapy Alone in R/R FLT3 Mutated AML